CCT245737

Alias: CCT 245737; CCT245737; CCT-245737
Cat No.:V2732 Purity: ≥98%
CCT245737 (CCT-245737) is a novel, potent, orally bioavailable and selective ATP-competitive inhibitor of CHK1 (checkpoint kinase 1) with anticancer activity.
CCT245737 Chemical Structure CAS No.: 1489389-18-5
Product category: Chk
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
5mg
10mg
25mg
50mg
100mg
250mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Purity & Quality Control Documentation

Purity: ≥98%

Product Description

CCT245737 (CCT-245737) is a novel, potent, orally bioavailable and selective ATP-competitive inhibitor of CHK1 (checkpoint kinase 1) with anticancer activity. It exhibits selectivity over these enzymes that is greater than 5000 times. Without raising toxicity, CCT245737 increased the antitumor activity of gemcitabine to a higher extent than higher doses of either drug alone. An increase in plasma and tumoconcentrations between 3 and 100 mg/kg is seen in CCT2457374. The residual weak in vitro hERG inhibition was lessened by CCT245737's low anticipated doses and exposures in humans.

Biological Activity I Assay Protocols (From Reference)
Targets
Chk1 (IC50 = 1.3 nM); Chk2 (IC50 = 2440 nM); ERK8 (IC50 = 130 nM); PKD1 (IC50 = 298 nM); RSK2 (IC50 = 361 nM); RSK1 (IC50 = 362 nM); FLT3 (IC50 = 582 nM); MARK3 (IC50 = 698 nM); NUAK1 (IC50 = 711 nM); CLK2 (IC50 = 2440 nM); BRSK1 (IC50 = 1660 nM); AMPK (IC50 = 2970 nM); PHK (IC50 = 3470 nM); CDK2/CyclA (IC50 = 3850 nM); CDK1/CyclB (IC50 = 9030 nM)
ln Vitro
CCT245737 (10 µM) demonstrates >80% inhibition of a panel of 124 kinases, with IC50s of 130, 298, 361, and 362 nM for ERK8, PKD1, RSK2, and RSK1 among them[1]. In HT29, SW620, MiaPaCa-2, and Calu6 cell lines, CCT245737 obliterates a G2 checkpoint induced by VP-16; its IC50 values range from 30 to 220 nM[2].
ln Vivo
CCT245737 (150 mg/kg p.o.) and LY 188011 (100 mg/kg iv) together suppress tumor growth in HT29 colon cancer xenografts. In SW620 human colon cancer xenografts, CCT245737 (300 mg/kg, p.o.) also prevents the autophosphorylation of pSer296 CHK1 that is induced by LY 188011 (60 mg/kg iv) after 24 hours[1]. In an Eμ-Myc mouse model of human B-cell lymphocytic leukemia, CCT245737 (150 mg/kg, p.o.) by itself dramatically suppresses tumor growth[2].
Enzyme Assay
CCT245737 (150 mg/kg p.o.) and LY 188011 (100 mg/kg iv) together suppress tumor growth in HT29 colon cancer xenografts. In SW620 human colon cancer xenografts, CCT245737 (300 mg/kg, p.o.) also prevents the autophosphorylation of pSer296 CHK1 that is induced by LY 188011 (60 mg/kg iv) after 24 hours[1]. In an Eμ-Myc mouse model of human B-cell lymphocytic leukemia, CCT245737 (150 mg/kg, p.o.) by itself dramatically suppresses tumor growth[2].
Cell Assay
Cytotoxicity is quantified by utilizing a 96-hour Sulforhodamine B (SRB) assay to find the drug concentration that results in 50% inhibition of tumor cell proliferation (GI50). Using a cell-based ELISA, the inhibition of intracellular CHK1 activity is assessed in order to disrupt a G2 checkpoint induced by VP-16 (mitosis induction assay, MIA). With nocodazole present, the G2 checkpoint abrogation (MIA) IC50 is ascertained using UCN01 as a positive control. The ability of a compound to induce mitosis in relation to its toxicity is measured by the activity index (AI), which is the ratio of MIA IC50 to 96-hour SRB GI50. The combination GI50 of CCT245737 is determined by performing standard potentiation studies with a fixed concentration (GI50) of either SN38 or LY 188011 in combination with a range of CCT245737 concentrations. Potentiation index (PI): the ratio of CCT245737's single GI50 to CCT245737's combination GI50 indicates how well CCT245737 can increase LY 188011 or SN38 cell killing. A PI value greater than one signifies a heightened genotoxic activity. Furthermore, to ascertain the degree to which CCT245737 augments drug cytotoxicity in comparison with the genotoxic agent alone, i.e. conventional PI (ratio GI50 genotoxic alone: GI50 genotoxic combined with non-toxic CCT245737 concentration, Con PI), a series of experiments is conducted using fixed, non- or minimally toxic concentrations of CCT245737 (≤GI20) with a variety of different concentrations of LY 188011 or SN38[2].
Animal Protocol
The female NCr athymic mice, aged 6-8 weeks, have s.c. injections of human HT29 colorectal carcinoma cells in their flanks. Dosing started five days after transplantation, or when the tumors reached a mean diameter of 5.5 mm. Compounds 4 (CCT245737) and 41 (150 mg/kg p.o.) are dosed in 10% DMSO 20% PEG 400, 5% Tween 80, and 65% water in the hours following each dose of LY 188011 (100 mg/kg i.v.). Days 0 through 14 are dosed in saline. Three times a week, body weights and tumor measurements are made. Tumors that grow to a predefined humane endpoint (mean diameter <15 mm) are individually culled from the animals[1].
References

[1]. Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737). J Med Chem. 2016 Jun 9;59(11):5221-37.

[2]. The clinical development candidate CCT245737 is an orally active CHK1 inhibitor with preclinical activity in RAS mutant NSCLC and Eμ-MYC driven B-cell lymphoma. Oncotarget. 2016 Jan 19;7(3):2329-42.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C16H16F3N7O
Molecular Weight
379.34
Exact Mass
379.14
Elemental Analysis
C, 50.66; H, 4.25; F, 15.02; N, 25.85; O, 4.22
CAS #
1489389-18-5
Appearance
White to off-white solid powder
SMILES
C1CO[C@H](CN1)CNC2=CC(=NC=C2C(F)(F)F)NC3=NC=C(N=C3)C#N
InChi Key
YBYYWUUUGCNAHQ-LLVKDONJSA-N
InChi Code
InChI=1S/C16H16F3N7O/c17-16(18,19)12-8-25-14(26-15-9-22-10(4-20)5-24-15)3-13(12)23-7-11-6-21-1-2-27-11/h3,5,8-9,11,21H,1-2,6-7H2,(H2,23,24,25,26)/t11-/m1/s1
Chemical Name
5-[[4-[[(2R)-morpholin-2-yl]methylamino]-5-(trifluoromethyl)pyridin-2-yl]amino]pyrazine-2-carbonitrile
Synonyms
CCT 245737; CCT245737; CCT-245737
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
DMSO: ~75 mg/mL (~197.7 mM)
Water: <1 mg/mL
Ethanol: ~9 mg/mL (~23.7 mM)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.6362 mL 13.1808 mL 26.3616 mL
5 mM 0.5272 mL 2.6362 mL 5.2723 mL
10 mM 0.2636 mL 1.3181 mL 2.6362 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration mg/mL;

Method for preparing DMSO stock solution mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation:Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Biological Data
  • CCT245737

    Structure and cellular pharmacology of CCT245737.Oncotarget.2016 Jan 19;7(3):2329-42.
  • CCT245737

    Summary of the pharmacokinetic and pharmacodynamic properties of CCT245737 in vivo.Oncotarget.2016 Jan 19;7(3):2329-42.
  • CCT245737

    Therapeutic activity of CCT245737 in combination with gemcitabine or irinotecan in human tumor xenografts.Oncotarget.2016 Jan 19;7(3):2329-42.
  • CCT245737

    Development and validation of a pharmacodynamic biomarker assay for CCT245737 activity in human lung tumor xenografts.Oncotarget.2016 Jan 19;7(3):2329-42.
  • CCT245737

    Antitumor activity of single-agent CCT245737 in an Eμ-Myc mouse model of human B-cell lymphocytic leukemia.Oncotarget.2016 Jan 19;7(3):2329-42.
Contact Us